Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1992;79:14-18
© 1992 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LEDUC, L.
Right arrow Articles by COTTON, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LEDUC, L.
Right arrow Articles by COTTON, D. B.

Coagulation Profile in Severe Preeclampsia

LINE LEDUC, MD., JAMES M. WHEELER, MD, MPH., BRIAN KIRSHON, MD., PATRICIA MITCHELL, MD. and DAVID B. COTTON, MD

From the Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas

Abstract

One hundred women with severe preeclampsia or chronic hypertension with superimposed preeclampsia were seen during a 2-year period. We sought to determine whether a normal platelet count assures that no other clinically significant clotting abnormalities are present, and what level of thrombocytopenia predicts a risk of abnormalities in other coagulation indices. Fifty women had platelet counts below 150,000/µL, of whom 13 had a fibrinogen level below 300 mg/dL and two had a prolonged prothrombin time (PT) or partial thromboplastin time (PTT). The admission platelet count was an excellent predictor of subsequent thrombocytopenia (r=0.829, P < .001). No subject had an abnormal fibrinogen level or prolonged PT or PTT in the absence of thrombocytopenia. When monitoring intrapartum coagulation indices in preeclampsia, one can safely follow only the platelet count at admission and subsequently, reserving PT and PTT and fibrinogen levels for those cases complicated by counts less than 100,000/µL.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. R. Davies, R. Fernando, and S. P. Hallworth
Hemostatic Function in Healthy Pregnant and Preeclamptic Women: An Assessment Using the Platelet Function Analyzer (PFA-100(R)) and Thromboelastograph(R)
Anesth. Analg., February 1, 2007; 104(2): 416 - 420.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
W. M. BARRON, P. HECKERLING, J. U. HIBBARD, and S. FISHER
Reducing Unnecessary Coagulation Testing in Hypertensive Disorders of Pregnancy
Obstet. Gynecol., September 1, 1999; 94(3): 364 - 370.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Obstetricians and Gynecologists.